GARY E DENG

Summary

Affiliation: Memorial Sloan-Kettering Cancer Center
Country: USA

Publications

  1. ncbi To what extent do cancer patients use complementary and alternative medicine?
    Gary Deng
    Integrative Medicine Service, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Nat Clin Pract Oncol 2:496-7. 2005
  2. ncbi Functional magnetic resonance imaging (fMRI) changes and saliva production associated with acupuncture at LI-2 acupuncture point: a randomized controlled study
    Gary Deng
    Integrative Medicine Service, Memorial Sloan Kettering Cancer Center, 1429 First Avenue, New York, NY 10021, USA
    BMC Complement Altern Med 8:37. 2008
  3. ncbi Acupuncture for the treatment of post-chemotherapy chronic fatigue: a randomized, blinded, sham-controlled trial
    Gary Deng
    Integrative Medicine Service, Memorial Sloan Kettering Cancer Center, 1429 First Avenue, New York, NY, 10021, USA
    Support Care Cancer 21:1735-41. 2013
  4. ncbi A phase II, randomized, controlled trial of acupuncture for reduction of Postcolectomy Ileus
    Gary Deng
    Integrative Medicine Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Ann Surg Oncol 20:1164-9. 2013
  5. ncbi A phase I/II trial of a polysaccharide extract from Grifola frondosa (Maitake mushroom) in breast cancer patients: immunological effects
    Gary Deng
    Integrative Medicine Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Cancer Res Clin Oncol 135:1215-21. 2009
  6. ncbi Randomized controlled trial of a special acupuncture technique for pain after thoracotomy
    Gary Deng
    Integrative Medicine Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    J Thorac Cardiovasc Surg 136:1464-9. 2008
  7. ncbi Research on integrative healthcare: context and priorities
    Gary Deng
    Memorial Sloan Kettering Cancer Center, 1429 First Avenue, New York, NY 10021, USA
    Explore (NY) 6:143-58. 2010
  8. ncbi A single arm phase II study of a Far-Eastern traditional herbal formulation (sho-sai-ko-to or xiao-chai-hu-tang) in chronic hepatitis C patients
    Gary Deng
    Integrative Medicine Service, Memorial Sloan Kettering Cancer Center, New York, NY 10021, United States
    J Ethnopharmacol 136:83-7. 2011
  9. ncbi Randomized, controlled trial of acupuncture for the treatment of hot flashes in breast cancer patients
    Gary Deng
    Memorial Sloan Kettering Cancer Center, 1429 First Ave, New York, NY 10021, USA
    J Clin Oncol 25:5584-90. 2007
  10. ncbi Complementary therapies for cancer-related symptoms
    Gary Deng
    Integrative Medicine Service, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 303, New York, New York 10021, USA
    J Support Oncol 2:419-26; discussion 427-9. 2004

Detail Information

Publications19

  1. ncbi To what extent do cancer patients use complementary and alternative medicine?
    Gary Deng
    Integrative Medicine Service, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Nat Clin Pract Oncol 2:496-7. 2005
  2. ncbi Functional magnetic resonance imaging (fMRI) changes and saliva production associated with acupuncture at LI-2 acupuncture point: a randomized controlled study
    Gary Deng
    Integrative Medicine Service, Memorial Sloan Kettering Cancer Center, 1429 First Avenue, New York, NY 10021, USA
    BMC Complement Altern Med 8:37. 2008
    ..Clinical studies suggest that acupuncture can stimulate saliva production and reduce xerostomia (dry mouth). We were interested in exploring the neuronal substrates involved in such responses...
  3. ncbi Acupuncture for the treatment of post-chemotherapy chronic fatigue: a randomized, blinded, sham-controlled trial
    Gary Deng
    Integrative Medicine Service, Memorial Sloan Kettering Cancer Center, 1429 First Avenue, New York, NY, 10021, USA
    Support Care Cancer 21:1735-41. 2013
    ..We conducted a randomized controlled trial to determine whether acupuncture reduces post-chemotherapy chronic fatigue more effectively than sham acupuncture...
  4. ncbi A phase II, randomized, controlled trial of acupuncture for reduction of Postcolectomy Ileus
    Gary Deng
    Integrative Medicine Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Ann Surg Oncol 20:1164-9. 2013
    ..Postoperative ileus (POI) prolongs hospital stay and increases risk of postoperative complications. We conducted a randomized, sham-controlled trial to evaluate whether acupuncture reduces POI more effectively than sham acupuncture...
  5. ncbi A phase I/II trial of a polysaccharide extract from Grifola frondosa (Maitake mushroom) in breast cancer patients: immunological effects
    Gary Deng
    Integrative Medicine Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Cancer Res Clin Oncol 135:1215-21. 2009
    ..Whether oral administration in human produces measurable immunologic effects, however, is unknown...
  6. ncbi Randomized controlled trial of a special acupuncture technique for pain after thoracotomy
    Gary Deng
    Integrative Medicine Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    J Thorac Cardiovasc Surg 136:1464-9. 2008
    ..We sought to determine whether an acupuncture technique specially developed for a surgical oncology population (intervention) reduces pain or analgesic use after thoracotomy compared with a sham acupuncture technique (control)...
  7. ncbi Research on integrative healthcare: context and priorities
    Gary Deng
    Memorial Sloan Kettering Cancer Center, 1429 First Avenue, New York, NY 10021, USA
    Explore (NY) 6:143-58. 2010
    ..We propose a framework for setting priorities in integrative health research, list areas for discussion, and pose a few questions on a future research agenda...
  8. ncbi A single arm phase II study of a Far-Eastern traditional herbal formulation (sho-sai-ko-to or xiao-chai-hu-tang) in chronic hepatitis C patients
    Gary Deng
    Integrative Medicine Service, Memorial Sloan Kettering Cancer Center, New York, NY 10021, United States
    J Ethnopharmacol 136:83-7. 2011
    ..We conducted a phase II trial of SST in hepatitis C patients who were not candidates for interferon-based therapy to determine whether this agent is worthy of further study...
  9. ncbi Randomized, controlled trial of acupuncture for the treatment of hot flashes in breast cancer patients
    Gary Deng
    Memorial Sloan Kettering Cancer Center, 1429 First Ave, New York, NY 10021, USA
    J Clin Oncol 25:5584-90. 2007
    ..To determine the immediate and long-term effects of true acupuncture versus sham acupuncture on hot flash frequency in women with breast cancer...
  10. ncbi Complementary therapies for cancer-related symptoms
    Gary Deng
    Integrative Medicine Service, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 303, New York, New York 10021, USA
    J Support Oncol 2:419-26; discussion 427-9. 2004
    ..Botanicals or dietary supplements are popular but often problematic. Concurrent use of herbal products with mainstream medical treatment should be discouraged...
  11. ncbi Acupuncture: integration into cancer care
    Gary Deng
    Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Soc Integr Oncol 4:86-92. 2006
    ..Acupuncture is useful complementary therapy in cancer care. Its integration into regular oncology practice can improve the supportive care of cancer patients...
  12. ncbi Complementary therapies and integrative oncology in lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition)
    Barrie R Cassileth
    Laurance S Rockefeller Chair in Integrative Medicine, Chief, Integrative Medicine Service, Memorial Sloan Kettering Cancer Center, 1429 First Ave at Seventy Fourth St, New York, NY 10021, USA
    Chest 132:340S-354S. 2007
    ..Data on complementary therapies such as acupuncture, massage therapy, mind-body therapies, herbs and other botanicals, and exercise were evaluated. Recommendations were based on the strength of evidence and the risk-to-benefit ratio...
  13. ncbi Integrative Oncology Practice Guidelines
    GARY E DENG
    Memorial Sloan-Kettering Cancer Center, New York, NY, USA
    J Soc Integr Oncol 5:65-84. 2007
  14. ncbi Acupuncture for pain and dysfunction after neck dissection: results of a randomized controlled trial
    David G Pfister
    Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    J Clin Oncol 28:2565-70. 2010
    ..To determine whether acupuncture reduces pain and dysfunction in patients with cancer with a history of neck dissection. The secondary objective is to determine whether acupuncture relieves dry mouth in this population...
  15. ncbi Safety and pharmacokinetic trial of docetaxel plus an Astragalus-based herbal formula for non-small cell lung cancer patients
    Barrie R Cassileth
    Integrative Medicine Service, Memorial Sloan Kettering Cancer Center, 1429 First Avenue at 74th Street, New York, NY 10021, USA
    Cancer Chemother Pharmacol 65:67-71. 2009
    ..To study a commonly used Astragalus-based herbal formula previously found effective in non-small cell lung cancer (NSCLC) on the pharmacokinetics of docetaxel in patients with NSCLC...
  16. ncbi Complementary and alternative therapies for cancer
    Barrie R Cassileth
    Integrative Medicine Service, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Oncologist 9:80-9. 2004
    ..To encourage open communication of CAM use by patients, oncologists should be knowledgeable about the most popular remedies and know where to find reliable information for themselves and for their patients...
  17. ncbi Evaluation of widely consumed botanicals as immunological adjuvants
    Govind Ragupathi
    Laboratory of Tumor Vaccinology, Melanoma and Sarcoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, United States
    Vaccine 26:4860-5. 2008
    ..We describe here the results obtained using this s.c. immunization model with seven botanicals purported to have immune stimulant effects...
  18. ncbi Integrative oncology: complementary therapies for pain, anxiety, and mood disturbance
    Gary Deng
    Assistant Member, Integrative Medicine Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
    CA Cancer J Clin 55:109-16. 2005
    ..The authors summarize the research on these modalities and discuss the rationale, expectation, and necessary precautions involved with combining complementary therapies and mainstream care. Practical clinical issues are addressed...
  19. ncbi Inhibition of human dendritic cell activation by hydroethanolic but not lipophilic extracts of turmeric (Curcuma longa)
    Joseph Krasovsky
    Laboratory of Tumor Immunology and Immunotherapy, The Rockefeller University, New York, New York, USA
    Planta Med 75:312-5. 2009
    ..Harnessing the immune effects of turmeric may benefit from specifically targeting the active fractions...

Research Grants1